Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration

References

• Abenavoli L, Capasso R, Milic N, et al. (2010). Milk thistle in liver diseases: past, present, future. Phytother Res 24:1423–32
   PubMed Web of Science ®Google Scholar
• Ahn HK, Jung M, Sym SJ, et al. (2014). A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol 74:277–82
   PubMed Web of Science ®Google Scholar
• Al-Hilal TA, Alam F, Byun Y. (2013). Oral drug delivery systems using chemical conjugates or physical complexes. Adv Drug Deliv Rev 65:845–64
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen E, Molnar LK, et al. (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505–15
   PubMed Web of Science ®Google Scholar
• Almeida PV, Shahbazi MA, Makila E, et al. (2014). Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors. Nanoscale 6:10377–87
   PubMed Web of Science ®Google Scholar
• Angelico R, Ceglie A, Sacco P, et al. (2014). Phyto-liposomes as nanoshuttles for water-insoluble silybin-phospholipid complex. Int J Pharm 471:173–81
   PubMed Web of Science ®Google Scholar
• Cai Z, Wang Y, Zhu LJ, et al. (2010). Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab 11:197–207
   PubMed Web of Science ®Google Scholar
• Cao X, Deng W, Fu M, et al. (2013). Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs. Eur J Pharm Sci 48:64–71
   PubMed Web of Science ®Google Scholar
• Choi KY, Chung H, Min KH, et al. (2010). Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 31:106–14
   PubMed Web of Science ®Google Scholar
• Croy SR, Kwon GS. (2006). Polymeric micelles for drug delivery. Curr Pharm Des 12:4669–84
   PubMed Web of Science ®Google Scholar
• Dahmani FZ, Yang H, Zhou J, et al. (2012). Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation. Eur J Pharm Sci 47:179–89
   PubMed Web of Science ®Google Scholar
• des Rieux A, Fievez V, Theate I, et al. (2007). An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. Eur J Pharm Sci 30:380–91
   PubMed Web of Science ®Google Scholar
• El-Samaligy MS, Afifi NN, Mahmoud EA. (2006). Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 308:140–8
   PubMed Web of Science ®Google Scholar
• Gazak R, Svobodova A, Psotova J, et al. (2004). Oxidised derivatives of silybin and their antiradical and antioxidant activity. Bioorg Med Chem 12:5677–87
   PubMed Web of Science ®Google Scholar
• Kim SK, Huh J, Kim SY, et al. (2011). Physicochemical conjugation with deoxycholic acid and dimethylsulfoxide for heparin oral delivery. Bioconjug Chem 22:1451–8
   PubMed Web of Science ®Google Scholar
• Kvasnicka F, Biba B, Sevcik R, et al. (2003). Analysis of the active components of silymarin. J Chromatogr A 990:239–45
   PubMed Web of Science ®Google Scholar
• Laffleur F, Roggla J, Idrees MA, et al. (2014). Chemical modification of hyaluronic acid for intraoral application. J Pharm Sci 103:2414–23
   PubMed Web of Science ®Google Scholar
• Lee Y, Nam JH, Shin HC, et al. (2001). Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent. Circulation 104:3116–20
   PubMed Web of Science ®Google Scholar
• Li H, Huo M, Zhou J, et al. (2010). Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N,O-hydroxyethyl chitosan micellar system. J Pharm Sci 99:4543–53
   PubMed Web of Science ®Google Scholar
• Li J, Huo M, Wang J, et al. (2012). Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials 33:2310–20
   PubMed Web of Science ®Google Scholar
• Li J, Yin T, Wang L, et al. (2015). Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel. Int J Pharm 483:38–48
   PubMed Web of Science ®Google Scholar
• Lian H, Zhang T, Sun J, et al. (2013). Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism. Mol Pharm 10:3447–58
   PubMed Web of Science ®Google Scholar
• Liang N, Sun S, Hong J, et al. (2015). In vivo pharmacokinetics, biodistribution and antitumor effect of paclitaxel-loaded micelles based on alpha-tocopherol succinate-modified chitosan. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2015.1045103
   Web of Science ®Google Scholar
• Liang Z, Yang Y, Wang H, et al. (2014). Inhibition of SIRT1 signaling sensitizes the antitumor activity of silybin against human lung adenocarcinoma cells in vitro and in vivo. Mol Cancer Ther 13:1860–72
   PubMed Web of Science ®Google Scholar
• Lin J, Wang X, Wu Q, et al. (2014). Development of Salvianolic acid B-Tanshinone II A-Glycyrrhetinic acid compound liposomes: formulation optimization and its effects on proliferation of hepatic stellate cells. Int J Pharm 462:11–18
   PubMed Web of Science ®Google Scholar
• Liu Q, Li J, Pu G, et al. (2015). Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2015.1031295
   Web of Science ®Google Scholar
• Luo Y, Prestwich GD. (1999). Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem 10:755–63
   PubMed Web of Science ®Google Scholar
• Mahmud A, Xiong XB, Aliabadi HM, et al. (2007). Polymeric micelles for drug targeting. J Drug Target 15:553–84
   PubMed Web of Science ®Google Scholar
• Mathot F, des Rieux A, Arien A, et al. (2007). Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier. J Control Release 124:134–43
   PubMed Web of Science ®Google Scholar
• Matsumura Y. (2006). [Micelle carrier system in clinical trial]. Nihon Rinsho 64:316–21
   PubMedGoogle Scholar
• Oh EJ, Park K, Kim KS, et al. (2010). Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release 141:2–12
   PubMed Web of Science ®Google Scholar
• Ohya Y, Takeda S, Shibata Y, et al. (2011). Evaluation of polyanion-coated biodegradable polymeric micelles as drug delivery vehicles. J Control Release 155:104–10
   PubMed Web of Science ®Google Scholar
• Rainone F. (2005). Milk thistle. Am Fam Physician 72:1285–8
   PubMed Web of Science ®Google Scholar
• Ramasamy K, Agarwal R. (2008). Multitargeted therapy of cancer by silymarin. Cancer Lett 269:352–62
   PubMed Web of Science ®Google Scholar
• Rezazadeh M, Emami J, Hasanzadeh F, et al. (2015). In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2014.954281
   PubMed Web of Science ®Google Scholar
• Rohilla R, Garg T, Bariwal J, et al. (2014). Development, optimization and characterization of glycyrrhetinic acid-chitosan nanoparticles of atorvastatin for liver targeting. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2014.977460
   Web of Science ®Google Scholar
• Rohilla R, Garg T, Goyal AK, et al. (2015). Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2014.945018
   Web of Science ®Google Scholar
• Takei Y, Maruyama A, Ferdous A, et al. (2004). Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronan-glycocalyx. FASEB J 18:699–701
   PubMed Web of Science ®Google Scholar
• Trappoliere M, Caligiuri A, Schmid M, et al. (2009). Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. J Hepatol 50:1102–11
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Liu Z, et al. (2012). In vivo evaluation of silybin nanosuspensions targeting liver. J Biomed Nanotechnol 8:760–9
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Wang Q, et al. (2014). Recent advances in the nanotechnology-based drug delivery of Silybin. J Biomed Nanotechnol 10:543–58
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang W, Liu T, et al. (2012). Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Biomaterials 33:2187–96
   PubMed Web of Science ®Google Scholar
• Zhang L, Yao J, Zhou J, et al. (2013a). Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. Int J Pharm 441:654–64
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang Y, Liang Z, et al. (2013b). Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells. PLoS One 8:e83699
   PubMed Web of Science ®Google Scholar
• Zou A, Huo M, Zhang Y, et al. (2012). Octreotide-modified N-octyl-O,N-carboxymethyl chitosan micelles as potential carriers for targeted antitumor drug delivery. J Pharm Sci 101:627–40
   PubMed Web of Science ®Google Scholar